United States · FDA National Drug Code directory

Sunitinib Malate

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 0093-8199_71bcc3b2-9dea-4700-af34-a9a5d2b708a2
Product NDC: 0093-8199
Form: CAPSULE
Composition / generic term: Sunitinib Malate
Labeler: Teva Pharmaceuticals USA, Inc.
Marketing category: ANDA
Marketing start / end (source format): 20211222
Source listing expiry: 20271231

Source-listed ingredients

SUNITINIB MALATE — 12.5 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

28 CAPSULE in 1 BOTTLE (0093-8199-28) · 0093-8199-28

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →